In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI

Caterina Mainero1, T Benner, A Radding

  • 1Athinoula Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, MA, USA. caterina@nmr.mgh.harvard.edu

Neurology
|July 31, 2009
PubMed
Abstract

Insights

Ultra-high field MRI visualized distinct multiple sclerosis (MS) cortical lesion types, correlating with disease severity and age. This advanced imaging may help assess MS pathology

Area of Science:

  • Neuroimaging
  • Magnetic Resonance Imaging (MRI)
  • Neuropathology

Background:

  • Multiple sclerosis (MS) involves complex brain pathology, including cortical lesions.
  • Accurate visualization and characterization of MS cortical lesions are crucial for understanding disease progression and clinical impact.

Purpose of the Study:

  • To utilize ultra-high field (7-Tesla) MRI to visualize and characterize histopathologically defined cortical lesion types in MS patients.
  • To investigate the contrast properties of different lesion types using various MRI sequences.
  • To explore the relationship between cortical lesion types and clinical data in MS.

Main Methods:

  • Acquisition of 7-Tesla MRI data, including 2D FLASH-T2*-weighted and T2-weighted TSE sequences.
  • Characterization of cortical lesions into types I, II, and III/IV based on neuropathological descriptions.
  • Analysis of lesion frequency, contrast-to-noise ratios, and correlation with clinical data.

Main Results:

  • 199 cortical lesions were detected in 16 MS patients.
  • Seven-tesla MRI enabled differentiation of MS cortical lesions into types I, II, and III/IV, with types III/IV being most frequent.
  • Type III/IV lesions were more prevalent in secondary progressive MS and associated with greater disability and older age.

Conclusions:

  • Seven-tesla MRI successfully visualized distinct histopathological cortical lesion types in MS.
  • This advanced imaging technique shows promise for assessing the contribution of cortical MS pathology to clinical disability, pending validation in larger cohorts.

Related Concept Videos